These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Assessment of the Hematopoietic Differentiation Potential of Human Pluripotent Stem Cells in 2D and 3D Culture Systems. Mora-Roldan GA; Ramirez-Ramirez D; Pelayo R; Gazarian K Cells; 2021 Oct; 10(11):. PubMed ID: 34831080 [TBL] [Abstract][Full Text] [Related]
8. Global MicroRNA Profiling Uncovers miR-206 as a Negative Regulator of Hematopoietic Commitment in Human Pluripotent Stem Cells. Flamant S; Chomel JC; Desterke C; Féraud O; Gobbo E; Mitjavila-Garcia MT; Foudi A; Griscelli F; Turhan AG; Bennaceur-Griscelli A Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30965622 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Smith JR; Vallier L; Lupo G; Alexander M; Harris WA; Pedersen RA Dev Biol; 2008 Jan; 313(1):107-17. PubMed ID: 18022151 [TBL] [Abstract][Full Text] [Related]
10. Progress and challenges in generating functional hematopoietic stem/progenitor cells from human pluripotent stem cells. Liu S; Xu Y; Zhou Z; Feng B; Huang H Cytotherapy; 2015 Apr; 17(4):344-58. PubMed ID: 25680303 [TBL] [Abstract][Full Text] [Related]
11. Pig epiblast stem cells depend on activin/nodal signaling for pluripotency and self-renewal. Alberio R; Croxall N; Allegrucci C Stem Cells Dev; 2010 Oct; 19(10):1627-36. PubMed ID: 20210627 [TBL] [Abstract][Full Text] [Related]
12. The balance of positive and negative effects of TGF-β signaling regulates the development of hematopoietic and endothelial progenitors in human pluripotent stem cells. Bai H; Xie YL; Gao YX; Cheng T; Wang ZZ Stem Cells Dev; 2013 Oct; 22(20):2765-76. PubMed ID: 23758278 [TBL] [Abstract][Full Text] [Related]
13. Application of small molecule CHIR99021 leads to the loss of hemangioblast progenitor and increased hematopoiesis of human pluripotent stem cells. Galat Y; Elcheva I; Dambaeva S; Katukurundage D; Beaman K; Iannaccone PM; Galat V Exp Hematol; 2018 Sep; 65():38-48.e1. PubMed ID: 29879440 [TBL] [Abstract][Full Text] [Related]
14. Development of hematopoietic stem and progenitor cells from human pluripotent stem cells. Chen T; Wang F; Wu M; Wang ZZ J Cell Biochem; 2015 Jul; 116(7):1179-89. PubMed ID: 25740540 [TBL] [Abstract][Full Text] [Related]
15. SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells. Chng Z; Teo A; Pedersen RA; Vallier L Cell Stem Cell; 2010 Jan; 6(1):59-70. PubMed ID: 20074535 [TBL] [Abstract][Full Text] [Related]
16. Human definitive hematopoietic specification from pluripotent stem cells is regulated by mesodermal expression of CDX4. Creamer JP; Dege C; Ren Q; Ho JTK; Valentine MC; Druley TE; Sturgeon CM Blood; 2017 Jun; 129(22):2988-2992. PubMed ID: 28408465 [TBL] [Abstract][Full Text] [Related]
17. Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Nostro MC; Cheng X; Keller GM; Gadue P Cell Stem Cell; 2008 Jan; 2(1):60-71. PubMed ID: 18371422 [TBL] [Abstract][Full Text] [Related]
18. Activin A and Wnt-dependent specification of human definitive endoderm cells. Toivonen S; Lundin K; Balboa D; Ustinov J; Tamminen K; Palgi J; Trokovic R; Tuuri T; Otonkoski T Exp Cell Res; 2013 Oct; 319(17):2535-44. PubMed ID: 23954819 [TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells. Hexum MK; Tian X; Kaufman DS Methods Mol Biol; 2011; 767():433-47. PubMed ID: 21822894 [TBL] [Abstract][Full Text] [Related]
20. Modulation of Wnt and Activin/Nodal supports efficient derivation, cloning and suspension expansion of human pluripotent stem cells. Ai Z; Niu B; Duan K; Si C; Wang S; Xiang L; Zhu X; Zhu Q; Feng C; Yin Y; Zhao S; Kong R; Ji W; Li T Biomaterials; 2020 Aug; 249():120015. PubMed ID: 32311594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]